Atlas Trials

Glomerulosclerosis, Focal Segmental

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Glomerulosclerosis, Focal Segmental

RecordFirmDate
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. (NCT05505500)University of Michigan2022-04-18
A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease (NCT04387448)Goldfinch Bio, Inc.2020-07-28
Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis (NCT04340362)Vertex Pharmaceuticals Incorporated2020-06-08
A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN) (NCT04235621)Goldfinch Bio, Inc.2019-12-20
The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) (NCT03949972)Prof. Dr. Paul Brinkkoetter2018-04-01
A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS) (NCT02000440)GlaxoSmithKline2014-07-01
Nephrotic Syndrome Study Network (NCT01209000)University of Michigan2010-04-01
Podocyte Retinoids (NCT00098020)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2004-11-26

Track Glomerulosclerosis, Focal Segmental automatically

Every clearance here is in the API, with alerts when new ones post.